Skip to Main Content

Author Details

Veronica Clavijo Jordan
Harvard Medical School
1971
790
122
PMIDPaper TitleJournal TitlePublished Year
36790154[Management of suicidal crisis: mentalizing as a team].Rev Med Suisse2023
37818152Molecular magnetic resonance imaging of liver inflammation using an oxidatively activated probe.JHEP Rep2023
37873284Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.bioRxiv2023
37254150Progesterone from ovulatory menstrual cycles is an important cause of breast cancer.Breast Cancer Res2023
37051756Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.Haematologica2023
37110126Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.Metabolites2023
37358260A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.Cancer Discov2023
36790154[Management of suicidal crisis: mentalizing as a team].Rev Med Suisse2023
37097498Investigations into the Signaling Pathways Involving Glucose-Stimulated Zinc Secretion (GSZS) from Prostate Epithelial Cells In Vitro and In Vivo.Mol Imaging Biol2023
37873284Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.bioRxiv2023
37818152Molecular magnetic resonance imaging of liver inflammation using an oxidatively activated probe.JHEP Rep2023
37254150Progesterone from ovulatory menstrual cycles is an important cause of breast cancer.Breast Cancer Res2023
37051756Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.Haematologica2023
37110126Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.Metabolites2023
37097498Investigations into the Signaling Pathways Involving Glucose-Stimulated Zinc Secretion (GSZS) from Prostate Epithelial Cells In Vitro and In Vivo.Mol Imaging Biol2023
37358260A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.Cancer Discov2023
34728551PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer.Mol Cancer Res2022
35594462Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures.Cancer J2022
36245043HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia.Nat Commun2022
35902048Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy.Transplant Cell Ther2022
35939923Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging.J Trace Elem Med Biol2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
35360069Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer.Front Endocrinol (Lausanne)2022
36194842Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.JCO Clin Cancer Inform2022
36259537Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation.Elife2022
35290592Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer.Target Oncol2022
34728551PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer.Mol Cancer Res2022
35093588Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver.Cell Mol Gastroenterol Hepatol2022
34645926Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.Bone Marrow Transplant2022
34525179The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.Blood2022
35594462Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures.Cancer J2022
35360069Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer.Front Endocrinol (Lausanne)2022
35939923Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging.J Trace Elem Med Biol2022
36245043HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia.Nat Commun2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
35902048Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy.Transplant Cell Ther2022
36194842Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.JCO Clin Cancer Inform2022
36259537Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation.Elife2022
35290592Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer.Target Oncol2022
35093588Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver.Cell Mol Gastroenterol Hepatol2022
34645926Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.Bone Marrow Transplant2022
34525179The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.Blood2022
33177154Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer.Mol Cancer Ther2021
34079900Comprehensive Structure-Activity Profiling of Micheliolide and its Targeted Proteome in Leukemia Cells via Probe-Guided Late-Stage C-H Functionalization.ACS Cent Sci2021
33857288PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress.J Exp Med2021
34122330Imaging Beta-Cell Function in the Pancreas of Non-Human Primates Using a Zinc-Sensitive MRI Contrast Agent.Front Endocrinol (Lausanne)2021
34229108Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD).Eur J Med Chem2021
33667359Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors.Cell Stem Cell2021
33507742Manganese(II)-Based Responsive Contrast Agent Detects Glucose-Stimulated Zinc Secretion from the Mouse Pancreas and Prostate by MRI.Inorg Chem2021
34086013Magnetic Resonance Imaging Detection of Glucose-Stimulated Zinc Secretion in the Enlarged Dog Prostate as a Potential Method for Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.Invest Radiol2021
  • 1 - 50 of 1,580

Recommended Authors

Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 1
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 6
Mona Shehata
University of Cambridge
Career Start Year 2004
Number of shared co-authors 0
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 1
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
Jeffrey A Dodge
Lilly Research Laboratories
Career Start Year 1996
Number of shared co-authors 0
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Career Start Year 1993
Number of shared co-authors 1
Barry R Davies
Oncology R&D
Career Start Year 1992
Number of shared co-authors 5
Powel H Brown
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 6
Maria Lucia Hirata Katayama
School of Medicine of Sao Paulo University
Career Start Year 1991
Number of shared co-authors 0
J Dinny Graham
Westmead Institute for Medical Research
Career Start Year 1990
Number of shared co-authors 0
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 6
Caroline Seynaeve
Erasmus Medical Center
Career Start Year 1990
Number of shared co-authors 5
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Career Start Year 1989
Number of shared co-authors 0
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year 1987
Number of shared co-authors 0
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 14
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 1
Alfredo A Molinolo
University of California
Career Start Year 1984
Number of shared co-authors 3
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 6
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Christine L Clarke
Westmead Institute for Medical Research, University of Sydney
Career Start Year 1978
Number of shared co-authors 6
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 5
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 9
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Career Start Year 1976
Number of shared co-authors 14
Erika Ginsburg
National Cancer Institute, National Institutes of Health
Career Start Year 1973
Number of shared co-authors 1
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 12
Anna DeFazio
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 3
Maria Mitzi Brentani
Sao Paulo University
Career Start Year 1964
Number of shared co-authors 0
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Career Start Year 1963
Number of shared co-authors 4

Collaborators

Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 41
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 37
Shanshan Pei
Zhejiang University Medical Center
Co-authored papers 27
Mohammad Minhajuddin
University of Colorado School of Medicine
Co-authored papers 24
Clayton A Smith
University of Colorado, Aurora CO.
Co-authored papers 22
Ruth M O'Regan
Co-authored papers 17
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 17
Eric A Ariazi
Co-authored papers 16
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 16
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Co-authored papers 16
Courtney L Jones
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 15
Alexander D Sherry
University of Texas MD Anderson Cancer Center
Co-authored papers 12
Biniam Adane
The Broad Institute of MIT and Harvard
Co-authored papers 12
Diana Abbott
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Co-authored papers 12
Haobin Ye
Institute of Metabolism & Integrative Biology, Fudan University
Co-authored papers 11
Maria Amaya
University of Colorado School of Medicine
Co-authored papers 10
James DeGregori
University of Colorado Anschutz Medical Campus
Co-authored papers 9
Travis Nemkov
University of Colorado Anschutz Medical Campus
Co-authored papers 9
Rachel Culp-Hill
University of Colorado Anschutz Medical Campus
Co-authored papers 8
Maura Gasparetto
University of Colorado School of Medicine
Co-authored papers 7
Anagha Inguva
University of Colorado School of Medicine
Co-authored papers 7
Ihor R Lemischka
Co-authored papers 7
Anna Krug
University of Colorado School of Medicine
Co-authored papers 7
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 5
Ramona F Swaby
Merck & Co., Inc.
Co-authored papers 5
Vadym Zaberezhnyy
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Mark A Gregory
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Vera J Suman
Mayo Clinic
Co-authored papers 4
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers 4
David A Rizzieri
Duke University Medical Center
Co-authored papers 4
Release 1.2